Drugmakers to work together to develop Ebola vaccine

London

LEADING drugmakers plan to work together to accelerate development of an Ebola vaccine and produce millions of doses of the most effective experimental product for use next year.

Johnson & Johnson said on Wednesday that it aims to produce at least one million doses of its two-step vaccine next year and has already discussed collaboration with Britain's GlaxoSmithKline, which is working on a rival vaccine.